# Mary Anne Toledo‐Tamula

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-anne-toledo-tamula/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,108 |
| Field | Neurofibromatosis and Schwannoma Cases |
| h-index | 16 |
| i10-index | 23 |
| Last Known Institution | National Institutes of Health |
| OpenAlex ID | https://openalex.org/A5059178945 |
| Works | 41 |

## Researcher papers

- [CD19/22 CAR T cells in children and young adults with B-ALL: phase 1 results and development of a novel bicistronic CAR](https://scholariq.org/papers/cd19-22-car-t-cells-in-children-and-young-adults-with-b-all-phase-1-results-and/)
- [Pain interference in youth with neurofibromatosis type 1 and plexiform neurofibromas and relation to disease severity, social‐emotional functioning, and quality of life](https://scholariq.org/papers/pain-interference-in-youth-with-neurofibromatosis-type-1-and-plexiform/)
- [Patient, Caregiver and Regimen Characteristics Associated With Adherence to Highly Active Antiretroviral Therapy Among HIV-Infected Children and Adolescents](https://scholariq.org/papers/patient-caregiver-and-regimen-characteristics-associated-with-adherence-to/)
- [Cognitive Functioning in School-Aged Children With Vertically Acquired HIV Infection Being Treated With Highly Active Antiretroviral Therapy (HAART)](https://scholariq.org/papers/cognitive-functioning-in-school-aged-children-with-vertically-acquired-hiv/)
- [Systematic Evaluation of Neurotoxicity in Children and Young Adults Undergoing CD22 Chimeric Antigen Receptor T-Cell Therapy](https://scholariq.org/papers/systematic-evaluation-of-neurotoxicity-in-children-and-young-adults-undergoing/)
- [Phase I Trial of Pirfenidone in Children with Neurofibromatosis 1 and Plexiform Neurofibromas](https://scholariq.org/papers/phase-i-trial-of-pirfenidone-in-children-with-neurofibromatosis-1-and-plexiform/)
- [Acceptance and commitment therapy in youth with neurofibromatosis type 1 (NF1) and chronic pain and their parents: A pilot study of feasibility and preliminary efficacy](https://scholariq.org/papers/acceptance-and-commitment-therapy-in-youth-with-neurofibromatosis-type-1-nf1-and/)
- [Development and Validation of the English Pain Interference Index and Pain Interference Index-Parent Report](https://scholariq.org/papers/development-and-validation-of-the-english-pain-interference-index-and-pain/)
- [Impact of MEK Inhibitor Therapy on Neurocognitive Functioning in NF1](https://scholariq.org/papers/impact-of-mek-inhibitor-therapy-on-neurocognitive-functioning-in-nf1/)
- [Diagnosis disclosure, medication hiding, and medical functioning among perinatally infected, HIV-positive children and adolescents](https://scholariq.org/papers/diagnosis-disclosure-medication-hiding-and-medical-functioning-among-perinatally/)
- [A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib](https://scholariq.org/papers/a-mixed-methods-study-of-medication-adherence-in-adults-with-neurofibromatosis/)

## Researcher topics

- [Neurofibromatosis and Schwannoma Cases](https://scholariq.org/topics/neurofibromatosis-and-schwannoma-cases/)
- [Meningioma and schwannoma management](https://scholariq.org/topics/meningioma-and-schwannoma-management/)
- [Tuberous Sclerosis Complex Research](https://scholariq.org/topics/tuberous-sclerosis-complex-research/)
- [Childhood Cancer Survivors' Quality of Life](https://scholariq.org/topics/childhood-cancer-survivors-quality-of-life/)
- [HIV/AIDS Research and Interventions](https://scholariq.org/topics/hiv-aids-research-and-interventions/)

## Researcher university

- [National Institutes of Health](https://scholariq.org/institutions/national-institutes-of-health/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.